<DOC>
	<DOCNO>NCT00159965</DOCNO>
	<brief_summary>The investigator propose treatment comorbid disorder ( depression , anxiety , impulsivity ) sertraline patient lone psychogenic nonepileptic seizure ( NES ) , result decrease number NES . The purpose study provide pilot test data inform future randomize control trial base hypothesis .</brief_summary>
	<brief_title>Treatments Psychogenic Nonepileptic Seizures ( NES )</brief_title>
	<detailed_description>This pilot , prospective , single center , randomize , placebo-controlled , double-blind trial , assess number NES patient treat flexible dose sertraline ( Zoloft ) . This study provide outcomes data effect size necessary future R01 , multi-center randomize control trial . Secondary objective variable include reduction depression , anxiety , impulsivity score , improvement psychosocial functioning . After diagnosed NES video electroencephalogram monitoring ( vEEG ) , 50 participant enrol monitor two week lead period baseline NES psychosocial symptom function . At week 2 , blindly randomize treatment arm flexible dose sertraline ( 25 200mg ) placebo control arm . The dose titrate 4 week 200mg dose limited side effect . The subject stay maximum fix dose next 4 week . At week 10 , subject may elect remain sertraline taper medication final two week treatment trial . After treatment trial , subject follow phone call month 4 , 8 , 12 enrollment ass seizure status , medication usage , global functioning . Upon enrollment , subject evaluate structured psychiatric neurological exam , bi-weekly , 30 60 minute appointment complete symptom function scale . They keep seizure diary prospectively , evaluate daily seizure activity . They give two week medication visit . In first phase study 12 patient screen 8 enrolled open label trial flexible dose sertraline . In second phase study , 38 patient enrol pilot , randomize , placebo-controlled trial .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Conversion Disorder</mesh_term>
	<mesh_term>Hysteria</mesh_term>
	<mesh_term>Dissociative Disorders</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Video electroencephalogram ( vEEG ) confirm diagnosis NES Have least one nonepileptic seizure per month Comorbid diagnosis either depression , anxiety , post traumatic stress disorder ( PTSD ) Able complete self report symptom scale Not receive optimize antidepressant medication Equivocal electroencephalogram ( EEG ) finding Current suicidality , litigation , selfmutilation Using monoamine oxidase inhibitor ( MAOIs ) , pimozide , sumatriptan Allergy/sensitivity sertraline Current alcohol/drug dependence Serious medical illness require current hospitalization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>nonepileptic seizure</keyword>
	<keyword>pseudoseizure</keyword>
	<keyword>conversion disorder</keyword>
	<keyword>psychogenic</keyword>
	<keyword>Depression</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Abuse</keyword>
	<keyword>post-traumatic stress disorder</keyword>
	<keyword>sertraline</keyword>
	<keyword>serotonin</keyword>
	<keyword>randomize control trial</keyword>
</DOC>